Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA.
Harvard Medical School, Boston, MA 02115, USA.
J Clin Endocrinol Metab. 2024 Feb 20;109(3):e883-e891. doi: 10.1210/clinem/dgad600.
Cardiovascular disease (CVD) is the leading cause of death among women. Adverse pregnancy outcomes (APOs) are cardiovascular risk factors that are unique to women and include gestational diabetes (GDM) and preeclampsia. While these risk factors emerge during the reproductive years and allow for early risk reduction counseling, they are often overlooked and not elicited by providers. This mini-review focuses primarily on GDM and preeclampsia, their relationship with CVD, mechanisms by which these conditions lead to CVD, and management, pharmacological and nonpharmacological, for the clinician who is caring for a woman with a history of an APO.
心血管疾病 (CVD) 是女性死亡的主要原因。不良妊娠结局 (APO) 是女性特有的心血管危险因素，包括妊娠期糖尿病 (GDM) 和子痫前期。虽然这些危险因素出现在生育年龄，并允许进行早期风险降低咨询，但它们经常被忽视，并且提供者不会询问。本迷你综述主要关注 GDM 和子痫前期、它们与 CVD 的关系、这些疾病导致 CVD 的机制，以及为有 APO 病史的女性提供护理的临床医生的管理，包括药理学和非药理学方法。
